CDH2 and hepatocellular carcinoma: Furthermore, in hepatocellular carcinoma (HCC), ZKSCAN3 facilitates epithelial-mesenchymal transition (EMT), as evidenced by changes in the expression patterns of EMT markers, including decreased E-cadherin and increased N-cadherin and vimentin levels.